Clinivation's Global Market Clearance services leverage our excellence in market clearance and many years of focused, successful experience in developing and supporting thousands of medtech market clearance applications in all of the major and emerging world markets. Our many years of successful experience spans from comprehensive initiation, support, and execution of the most complex Class III PMA programs to focused global market clearance initiatives.

Bracco Diagnostics Inc., the US-based subsidiary of Bracco Imaging S.p.A, develops and markets clinical agents for use in X-ray/Computed Tomography (CT), Nuclear Medicine and Magnetic Resonance Imaging (MRI) in the U.S. and Canada. Their leading products represent a significant share of the U.S. diagnostic contrast media market. With headquarters and research offices in Princeton, New Jersey, the company is also developing contrast agents for ultrasound procedures.

For more information, please visit http://usa.braccoimaging.com.

Bracco Imaging S.p.A. is one of the world's leading companies in the diagnostic imaging business. Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs and facilitate clinical solutions. Headquartered in Milan, Italy, Bracco Imaging operates in over 80 markets worldwide. Bracco Diagnostics Inc. is the U.S. subsidiary of Bracco Imaging.

Bracco Imaging is a subsidiary of Bracco S.p.A., the holding company of the Bracco Group which also markets Ethical and Over The Counter (OTC) pharmaceutical products in Italy as well as Advanced Medical Technology systems worldwide. Furthermore, the Bracco Group offers diagnostic services through the Milan-based Centro Diagnostico Italiano (Italian Diagnostic Center).

For more information, please visit www.braccoimaging.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.